Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in VRDN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 15.4M | $300.8M | +6.9% | 18.126% | 0.02% |
| 2 | BlackRock, Inc. | 7.8M | $153.2M | +21.8% | 9.230% | 0.00% |
| 3 | Bellevue Group AG | 6.7M | $131.6M | +54.3% | 7.927% | 3.13% |
| 4 | STATE STREET CORP | 4.7M | $91.4M | +34.8% | 5.507% | 0.00% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $81.5M | — | 4.911% | 0.00% |
| 6 | Fairmount Funds Management LLC | 3.9M | $76.6M | 0.0% | 4.613% | 5.53% |
| 7 | VR Adviser, LLC | 3.9M | $75.9M | 0.0% | 4.576% | 2.83% |
| 8 | Paradigm Biocapital Advisors LP | 3.1M | $61.6M | +118.2% | 3.711% | 1.26% |
| 9 | WELLINGTON MANAGEMENT GROUP LLP | 3.1M | $60.2M | +56.2% | 3.628% | 0.01% |
| 10 | CITADEL ADVISORS LLC | 2.4M | $46.6M | +239.9% | 2.808% | 0.02% |
| 11 | Kynam Capital Management, LP | 2.3M | $45.8M | +59.2% | 2.760% | 2.86% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.3M | $45.6M | +17.1% | 2.750% | 0.00% |
| 13 | BALYASNY ASSET MANAGEMENT LLC | 2.3M | $45.3M | +359.6% | 2.729% | 0.16% |
| 14 | ALLIANCEBERNSTEIN L.P. | 1.4M | $43.3M | -1.6% | 1.641% | 0.01% |
| 15 | Novo Holdings A/S | 2.0M | $39.1M | -16.0% | 2.357% | 3.17% |
| 16 | BAKER BROS. ADVISORS LP | 2.0M | $38.6M | 0.0% | 2.324% | 0.22% |
| 17 | TANG CAPITAL MANAGEMENT LLC | 1.8M | $35.1M | 0.0% | 2.113% | 1.78% |
| 18 | Fisher Asset Management, LLC | 1.8M | $34.6M | -0.7% | 2.084% | 0.01% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.6M | $32.1M | — | 1.935% | 0.00% |
| 20 | GOLDMAN SACHS GROUP INC | 1.6M | $31.1M | +25.9% | 1.876% | 0.00% |
| 21 | Avoro Capital Advisors LLC | 1.5M | $29.3M | 0.0% | 1.768% | 0.30% |
| 22 | Deep Track Capital, LP | 1.4M | $27.3M | -44.8% | 1.643% | 0.56% |
| 23 | D. E. Shaw & Co., Inc. | 1.3M | $24.7M | +26.2% | 1.488% | 0.02% |
| 24 | PERCEPTIVE ADVISORS LLC | 1.2M | $22.9M | -61.5% | 1.380% | 0.45% |
| 25 | BANK OF AMERICA CORP /DE/ | 1.2M | $22.8M | +17.5% | 1.371% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in VRDN — a direct measure of their conviction.
Filings activity in VRDN during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 221 | 2.6% | 153.03% | 46.96 pp | $2.12B | 34% |
| Q4 2025 | 227 | +38% | 199.99% | +59.09 pp | $3.23B | +65% |
| Q3 2025 | 164 | 4.7% | 140.90% | +48.71 pp | $1.95B | +53% |
| Q2 2025 | 172 | 1.7% | 92.19% | +6.41 pp | $1.28B | +7.5% |
| Q1 2025 | 175 | +0.0% | 85.78% | 32.95 pp | $1.19B | 28% |
| Q4 2024 | 175 | +8.0% | 118.73% | 21.22 pp | $1.65B | 15% |
| Q3 2024 | 162 | +20% | 139.95% | +76.54 pp | $1.94B | +121% |
| Q2 2024 | 135 | — | 63.41% | — | $880M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying VRDN stock.
Based on Q1 2026 13F filings, institutional ownership of Viridian Therapeutics, Inc. stands at 153.0%, held across 221 reporting institutions.
FMR LLC is the largest reported institutional holder of VRDN, with approximately 15,379,377 shares worth $0.30B as of Q1 2026.
Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of VRDN, including CITADEL ADVISORS LLC, Fisher Asset Management, LLC.
Our composite Smart Money Score for VRDN is 40 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
49 institutions opened new positions in VRDN during Q1 2026, while 55 fully exited. 35 added to existing positions and 135 trimmed.
VRDN institutional ownership fell by 46.96 percentage points quarter-over-quarter, with a net change of -6 holders.
The top 10 institutions account for 50.8% of all reported 13F value in VRDN, and the top 25 account for 75.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Viridian Therapeutics, Inc. (VRDN) Institutional Ownership